biomarker panel
AMLo Biosciences Gets UKCA Mark for Melanoma Biomarker Test
The test, which is marketed in the US by Avero Diagnostics, is designed to identify early-stage melanomas at low risk of progression.
InfanDx Restructures After Halting Development of Hypoxic-Ischemic Encephalopathy Test
An in-depth analysis of biomarker validation study results for the firm's hypoxic-ischemic encephalopathy early detection tests raised doubts about its generalizability.
Biocare Medical Acquires Empire Genomics
The company believes its existing technology portfolio will be complemented by Empire's molecular probe business, better aiding cancer research and diagnostics.
SeekIn Nabs CE Mark for Cancer Assay
The biotech firm said its inexpensive and noninvasive test improves on existing screening methods and could help expand access to early cancer detection.
Valted Seq Lands Exclusive Rights to Evaluate Johns Hopkins Neurodegenerative Disease Dx Assays
The biomarker assays could one day be used as companion diagnostics for new treatments of Parkinson's and related diseases.
Feb 12, 2020
Dec 10, 2019
Nov 19, 2019
Oct 30, 2019
Sep 10, 2019
Jun 26, 2019
Vermillion Eyes $17M in Public Offering of Stock
Jun 25, 2019